The China, India and Japan Market for Hemostats Is Divided Into Two Categories: Passive and Active; This Market Will Continue to Witness Nearly Double-Digit Growth by 2022

/EINPresswire.com/ -- VANCOUVER, BC --(Marketwired - July 27, 2016) - According to a new series of reports on the Asia-Pacific markets for wound and tissue management by iData Research (www.idataresearch.com), the China, India and Japan hemostats markets are increasing in value year after year, but the market remains very price sensitive. As a result, coupled with a lack of reimbursement for advanced hemostatic products in the region, the less expensive oxidized regenerated cellulose (ORC) based products, gelatin sponges and local hemostatic gauzes account for a dominant share of the hemostat market in terms of volume and value.

The market for hemostats in Asia-Pacific includes ORC, thrombin, collagen, gelatin and combinations of thrombin with passive hemostatic agents, as well as polysaccharide, first responder hemostats and locally produced hemostatic gauze sheets. Unit sales in the Indian hemostat market are expected to more than double by 2022. The Chinese market for hemostats is expecting nearly double-digit growth over the forecast period while the average selling price (ASP) of hemostatic products in the region is expected to steadily decline over the same period. However, factors such as an expansion of private hospital chains, a shift to minimally invasive laparoscopic procedures, increase in government spending on health care and growing awareness of the benefits of active hemostats such as reduced surgical times are expected to contribute towards higher sales and ASP of the more expensive thrombin and combination hemostats.

"The interest in patient safety has driven the hemostat industry to seek safer alternatives," explains Dr. Kamran Zamanian, CEO of iData. "More expensive synthetic hemostats, which are free of animal- or human-derived products, are expected to become popular alternatives among surgeons in the Asia-Pacific region."

Ethicon is the leading competitor in the Asia-Pacific hemostat market. Its products include Surgicel® and Surgiflo®. The Surgicel® family of absorbable hemostats consists of ORC-based products, which include different variants such as fibrillary, besides the regular inexpensive version. Ethicon is able to bundle several of its products together, which protects it from the price wars between local manufacturers.

The remaining combined hemostat market share of over 50% across Asia-Pacific is split between Aegis Lifesciences, B.Braun, Biocer, EU Care, Hemcon Medical Technologies, Meril Life Sciences, MIL Laboratories Pvt. Ltd, Stryker, C.R.Bard (Davol), Hangzhou Singclean Medical Products Co Ltd, Wuxi BIOT Biology Technology Co. Ltd, Beijing Datsing Bio-Tech Co.Ltd, Shenzhen Lian Da Sponge Product Co. Ltd, Takeda Pharmaceuticals and other local distributors and manufacturers of hemostatic gauze products.

For Further Information

More on the hemostats market in the Asia-Pacific region can be found in a series of report suites published by iData Research entitled the Japanese Market Report Suite for Wound and Tissue Management, Chinese Market Report Suite for Wound and Tissue Management and the Indian Market Report Suite for Wound and Tissue Management. The suites cover reports on the following markets: Wound Closure, Moist Dressings, Antimicrobial Dressings, Interactive Dressings, Hemostats, Tissue Sealant, Anti-Adhesion, and Negative Pressure Wound Therapy.

The iData report series on wound and tissue management covers the United States, Brazil, India, China, Japan and 15 countries in Europe. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about wound and tissue management market data, register online or email us at info@idataresearch.net for an Japanese Market Report Suite for Wound and Tissue Management, Chinese Market Report Suite for Wound and Tissue Management and the Indian Market Report Suite for Wound and Tissue Management brochure and synopsis.

About iData Research

iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Wound Management, Orthopedics, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Large & Small Joints, Anesthesiology, Ophthalmics, Dental Operatory Equipment and more.

Contact Info
Marvin Cidamon
Marketing Coordinator
iData Research Inc.
604-266-6933 Ext. 205
marvinc@idataresearch.net

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.